5792
P. Va, W. R. Roush / Tetrahedron 63 (2007) 5768–5796
0.854 mmol), DMAP (30 mg, 0.244 mmol), THF (0.5 mL),
and 2,4,6-trichlorobenzoyl chloride (61 mL, 0.390 mmol)
were used. Purification of the crude product by flash column
chromatography afforded 76 (179 mg, 99%) as a colorless
oil: [a]2D5 +13ꢁ (c 0.18, CHCl3); 1H NMR (400 MHz,
CDCl3) d 5.74–5.81 (m, 2H), 5.43 (app dd, J¼4.8, 8.4 Hz,
2H), 5.33 (d, J¼16.8 Hz, 1H), 5.21–5.26 (m, 1H), 5.22 (d,
J¼11.6 Hz, 1H), 4.69 (dd, J¼1.2, 9.2 Hz, 1H), 4.04 (app
q, J¼6.8 Hz, 2H), 3.72 (quint., J¼5.6, 1H), 3.67 (dd,
J¼1.6, 7.6 Hz, 1H), 3.60 (app q, J¼8.0 Hz, 1H), 1.99–2.32
(m, 7H), 1.94 (t, J¼2.8 Hz, 1H), 1.73–1.88 (m, 3H), 1.50–
1.66 (m, 2H), 1.38–1.48 (m, 1H), 1.44 (s, 3H), 1.43 (s,
3H), 1.31 (d, J¼6.8 Hz, 3H), 1.08 (d, J¼6.8 Hz, 3H), 0.98
(t, J¼8.0 Hz, 9H), 0.97 (app d, J¼8.0 Hz, 1H), 0.59–0.76
(m, 6H), 0.32 (br dd, J¼1.6, 9.2 Hz, 1H); 13C NMR
(100 MHz, CDCl3) d 211.2, 173.7, 136.1, 134.3, 126.0,
118.5, 108.9, 87.5, 82.2, 82.2, 82.2, 80.7, 78.5, 77.4, 77.2,
75.4, 69.7, 63.9, 44.5, 40.4, 35.2, 33.3, 30.9, 29.2, 27.8,
27.1, 26.9, 22.3, 19.2, 16.1, 7.1, 5.4; IR (neat) 3310, 2049,
1978, 1732, 1238, 1170 cmꢀ1; HRMS (ES+) m/z for
C38H56FeO9SiNa [M+Na]+ calcd 763.2941, found
763.2944.
product (44 mg, 73%) as a colorless oil. In addition, an in-
separable mixture of products thought to arrive by enyne me-
tathesis (4 mg, 10%) was also isolated. Spectroscopic data
for the macrocycle product: [a]2D5 ꢀ34ꢁ (c 0.21, CHCl3);
1H NMR (400 MHz, CDCl3) d 6.15–6.26 (m, 2H), 5.72
(ddd, J¼3.6, 9.6, 15.2 Hz, 1H), 5.49–5.57 (m, 2H), 5.33
(app dd, J¼8.4, 15.6 Hz, 1H), 4.55 (app dd, J¼1.6, 9.6 Hz,
1H), 4.02 (app dt, J¼8.4, 26.0 Hz, 2H), 3.71 (app dd,
J¼1.6, 8.4 Hz, 1H), 3.20–3.35 (m, 3H), 2.19–2.36 (m,
3H), 1.82–2.03 (m, 3H), 1.95 (t, J¼2.8 Hz, 1H), 1.62–1.70
(m, 1H), 1.50–1.59 (m, 1H), 1.38–1.49 (m, 1H), 1.43 (s,
3H), 1.42 (s, 3H), 1.23 (d, J¼6.8 Hz, 3H), 1.15–1.28 (m,
2H), 1.06 (d, J¼6.4 Hz, 3H), 0.96 (t, J¼7.6 Hz, 9H), 0.57–
0.73 (m, 6H); 13C NMR (100 MHz, CDCl3) d 174.2,
138.4, 135.5, 131.3, 127.6, 125.7, 109.0, 83.0, 82.9, 82.3,
79.9, 78.5, 77.2, 75.1, 69.3, 44.2, 33.2, 32.0, 29.6, 28.6,
27.2, 27.1, 27.0, 22.5, 16.9, 15.6, 7.1, 5.6; IR (neat) 3310,
2950, 2874, 1732, 1378, 1237, 1170, 1053 cmꢀ1; HRMS
(ES+) m/z for C33H52O6SiNa [M+Na]+ calcd 595.3431,
found 595.3442.
Stannylalumination–protonolysis of the macrocycle alkyne
was accomplished using a procedure analogous to that out-
lined for the conversion of 40 to 41: macrocycle alkyne
from the preceding step 17 (44 mg, 0.077 mmol), THF
(1 mL), Bu3SnAlEt2 (1.1 mL of the 0.41 M solution,
0.45 mmol), and CuCN (2 mg, 0.022 mmol) were used. Pu-
rification of the crude product by flash column chromato-
graphy afforded the vinylstannane (38 mg, 58%) as
4.5.3. (E)-(R)-2-Methyl-hexa-3,5-dienoic acid (1R,2R)-1-
((R)-{(2S,5S)-5-[(E)-4-((4R,5R)-2,2-dimethyl-5-vinyl-
[1,3]dioxolan-4-yl)-but-3-enyl]-tetrahydro-furan-2-yl}-
triethylsilanyloxy-methyl)-2-methyl-pent-4-ynyl ester
(72). The oxidative decomplexation of 76 was accomplished
using a procedure analogous to that outlined for the con-
version of 39 to 40: 76 (45 mg, 0.061 mmol), acetone
(1 mL), and cerium ammonium nitrate (CAN) (67 mg,
0.122 mmol) were used. The crude product was purified
by flash column chromatography to afford 72 (35 mg,
1
a colorless oil: [a]2D5 ꢀ34.5ꢁ (c 0.11, CHCl3); H NMR
(400 MHz, CDCl3) d 6.15–6.26 (m, 2H), 5.72 (app ddd,
J¼3.6, 9.6, 15.2 Hz, 1H), 5.63 (app t, JSn–H¼70 Hz, 1H),
3
5.50–5.90 (m, 2H), 5.34 (dd, J¼8.8,15.2 Hz, 1H), 5.14 (dt,
1
3
95%) as a colorless oil: [a]2D5 ꢀ1.0ꢁ (c 0.10, CHCl3); H
J¼2.4 Hz, JSn–H¼31.6 Hz, 1H), 4.50 (d, J¼10.0 Hz, 1H),
NMR (400 MHz, CDCl3) d 6.29 (dt, J¼10.0, 16.8, 1H),
6.15 (dd, J¼10.4, 15.2 Hz, 1H), 5.72–5.82 (m, 3H), 5.42
(br dd, J¼1.6, 6.0, 15.6 Hz, 1H), 5.32 (d, J¼16.4 Hz, 1H),
5.22 (dd, J¼1.2, 10.4 Hz, 1H), 5.17 (d, J¼17.6, 1H), 5.06
(d, J¼10.0 Hz, 1H), 4.70 (dd, J¼2.0, 8.8 Hz, 1H), 4.04
(app q, J¼7.2 Hz, 2H), 3.71 (quint., J¼5.6 Hz, 1H), 3.67
(dd, J¼2.0, 7.2 Hz, 1H), 3.59 (q, J¼6.4 Hz, 1H), 3.21
(quint., J¼7.2 Hz, 1H), 1.98–2.36 (m, 5H), 1.94 (t,
J¼2.4 Hz, 1H), 1.74–1.88 (m, 2H), 1.57–1.66 (m, 1H),
1.46–1.56 (m, 1H), 1.43 (s, 3H), 1.42 (s, 3H), 1.36–1.45
(m, 2H), 1.29 (d, J¼6.8 Hz, 3H), 1.08 (d, J¼6.4 Hz, 3H),
0.95 (t, J¼6.8 Hz, 9H), 0.57–0.72 (m, 6H); 13C NMR
(100 MHz, CDCl3) d 173.7, 136.3, 136.2, 134.3, 132.5,
132.3, 125.8, 118.5, 117.0, 108.8, 82.4, 82.2, 82.2, 80.4,
78.4, 77.4, 75.3, 69.6, 42.8, 35.2, 33.3, 30.9, 29.2, 27.0,
26.9, 22.2, 17.0, 16.1, 7.0, 5.3; IR (neat) 3310, 2953, 2876,
1733, 1378, 1239 cmꢀ1; HRMS (ES+) m/z for C35H56O6-
SiNa [M+Na]+ calcd 623.3744, found 623.3748.
4.02 (app dt, J¼8.8, 24.0 Hz, 2H), 3.75 (d, J¼8.8 Hz, 1H),
3.15–3.35 (m, 3H), 2.33 (d, J¼13.2 Hz, 2H), 1.82–2.06
(m, 4H), 1.60–1.70 (m, 1H), 1.40–1.57 (m, 8H), 1.44 (s,
3H), 1.43 (s, 3H), 1.25–1.36 (m, 7H), 1.22 (d, J¼6.8 Hz,
3H), 1.18–1.24 (m, 2H), 0.96 (t, J¼8.0 Hz, 9H), 0.93–0.99
(m, 1H), 0.85–0.93 (m, 14H), 0.81 (d, J¼6.4 Hz, 3H),
0.55–0.72 (m, 6H); 13C NMR (100 MHz, CDCl3) d 174.2,
154.1, 138.5, 136.0, 135.8, 131.1, 127.5, 126.7, 125.7,
109.0, 83.1, 82.4, 80.1, 79.6, 77.2, 75.0, 45.4, 44.4, 33.0,
32.1, 29.7, 29.2, 29.1, 28.5, 27.4, 27.2, 27.1, 16.9, 14.8,
13.7, 9.6, 7.2, 5.7; IR (neat) 2954, 2931, 2873, 1732, 1237,
1170, 1053 cmꢀ1; HRMS (ES+) m/z for C45H80O6SiSnNa
[M+Na]+ calcd 887.4644, found 887.4655.
Iododestannylation of the vinylstannane intermediate was
accomplished using a procedure analogous to that outlined
for the conversion of 40 to 41: vinylstannane from the pre-
ceding step (121 mg, 0.140 mmol), dichloromethane
(2 mL), and NIS (38 mg, 0.17 mmol) were used. The crude
product was purified by flash column chromatography to af-
ford 77 (94 mg, 96%) as a colorless oil: [a]2D5 ꢀ63ꢁ (c 0.13,
CHCl3); 1H NMR (400 MHz, CDCl3) d 6.15–6.28 (m, 2H),
6.04 (s, 1H), 5.73 (s, 1H), 5.72 (ddd, J¼4.0, 10.4, 14.8 Hz,
1H), 5.53 (app dt, J¼9.2, 14.4 Hz, 2H), 5.33 (dd, J¼8.8,
15.2 Hz, 1H), 4.56 (d, J¼10.0 Hz, 1H), 4.02 (app dt,
J¼8.8, 28.4 Hz, 2H), 3.73 (d, J¼8.8 Hz, 1H), 3.20–3.37
(m, 3H), 2.28–2.48 (m, 3H), 2.00 (dd, J¼10.0, 13.6 Hz,
3H), 1.82–1.95 (m, 2H), 1.62–1.70 (m, 1H), 1.49–1.58 (m,
1H), 1.43 (s, 3H), 1.42 (s, 3H), 1.31–1.46 (m, 2H), 1.22 (d,
4.5.4. (4E,11E,13E)-(1S,6R,10R,15R,18R,19R,20S)-18-
((R)-3-Iodo-1-methyl-but-3-enyl)-8,8,15-trimethyl-19-
triethylsilanyloxy-7,9,17,23-tetraoxa-tricyclo-
[18.2.1.06,10]tricosa-4,11,13-trien-16-one (77). The ring
closing metathesis of 72 was accomplished using a procedure
analogous to that outlined for the conversion of 39 to
40: polyene 72 (63 mg, 0.105 mmol), dichloromethane
(105 mL), and Grubbs’ first generation catalyst (17 mg,
0.021 mmol) were used. The crude product was purified
by flash column chromatography to afford the macrocycle